A case of Lambert-Eaton myasthnic syndrome associated with small cell lung carcinoma representing as urinary retention

Acta Urologica Japonica

Volumn 49, Issue 9, 2003, Pages 535-538

  Uemura, Motohide ^a   Nishimura, Kensaku ^a   Nakagawa, Masahiro ^a   Mukai, Masatoshi ^a   Kanno, Nobufumi ^a   Miyoshi, Susumu ^a   Tanaka, Hisashi ^a   Kitaguchi, Masataka ^a  

^a NONE

Author keywords

Lambert Eaton myasthenic syndrome; Urinary retention

Indexed keywords

CISPLATIN; ETOPOSIDE; IRINOTECAN;

AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CASE REPORT; CYSTOSCOPY; CYSTOURETHROGRAPHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EATON LAMBERT SYNDROME; HUMAN; INTESTINE MOTILITY; LUNG SMALL CELL CANCER; MALE; MICTURITION DISORDER; MICTURITION REFLEX; MUSCLE WEAKNESS; MYASTHENIA; PROSTATECTOMY; TRANSURETHRAL RESECTION; URETHRA OBSTRUCTION; URINE RETENTION; URODYNAMICS;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; LUNG NEOPLASMS; MALE; URINARY BLADDER, NEUROGENIC; URINARY RETENTION; URODYNAMICS;

EID: 0242541796     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Waterman SA: Autonomic dysfunction in Lambert-Eaton myasthenic syndrome. Clin Auton Res 11: 145-154, 2001
2. Heath JP, Ewing DJ and Cull RE: Abnormalities of autonomic function in the Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 51: 436-439, 1988
3. Dau PC and Denys EH: Plasmapheresis and immunosuppressive drug therapy in the Lambert-Eaton syndrome. Ann Neurol 11: 570-575, 1982
4. Lundh H, Nilsson O and Rosén I: Treatment of Lambert-Eaton syndrome. Neurology 34: 1314-1330, 1984
5. Rubenstein AE, Horowitz SH and Bender AN: Cholinergic dysautonomia and Eaton-Lambert syndrome. Neurology 29: 720-723, 1979
6. Khurana RK, Koski CL and Mayer RF: Autonomic dysfunction in Lambert-Eaton myasthenic syndrome. J Neurol Sci 85: 77-86, 1988
7. Henriksson KG, Nilsson O, Rosén I, et al.: Clinical, neurophysiological and morphological findings in Eaton Lambert syndrome. Acta Neurol Scandinav 56: 117-140, 1977
8. Satoh K, Motomura M, Suzu H, et al.: Neurogenic bladder in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine. J Neurol Sci 183: 1-4, 2001
9. O'Neill JH, Murray NMF and Newsom-Davis J: The Lambert-Eaton myasthenic syndrome. a review of 50 cases. Brain 111: 577-596, 1988